Literature DB >> 23358277

Comparator bias: why comparisons must address genuine uncertainties.

Howard Mann1, Benjamin Djulbegovic.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23358277      PMCID： PMC3556798          DOI： 10.1177/0141076812474779

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  30 in total

Review 1.  Ethical issues in the design and conduct of randomised controlled trials.

Authors:  S J Edwards; R J Lilford; D A Braunholtz; J C Jackson; J Hewison; J Thornton
Journal:  Health Technol Assess       Date:  1998-12       Impact factor: 4.014

2.  Medical ethics and controlled trials.

Authors:  A B HILL
Journal:  Br Med J       Date:  1963-04-20

3.  Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Authors:  Christopher P Cannon; Sean P Curtis; Garret A FitzGerald; Henry Krum; Amarjot Kaur; James A Bolognese; Alise S Reicin; Claire Bombardier; Michael E Weinblatt; Désirée van der Heijde; Erland Erdmann; Loren Laine
Journal:  Lancet       Date:  2006-11-18       Impact factor: 79.321

Review 4.  Users' guide to detecting misleading claims in clinical research reports.

Authors:  Victor M Montori; Roman Jaeschke; Holger J Schünemann; Mohit Bhandari; Jan L Brozek; P J Devereaux; Gordon H Guyatt
Journal:  BMJ       Date:  2004-11-06

5.  The use of systematic reviews when designing studies.

Authors:  Nicola J Cooper; David R Jones; Alex J Sutton
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

6.  Recent trials in hypertension: compelling science or commercial speech?

Authors:  Bruce M Psaty; Noel S Weiss; Curt D Furberg
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

7.  NSAID trials and the choice of comparators--questions of public health importance.

Authors:  Bruce M Psaty; Noel S Weiss
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

8.  Articulating and responding to uncertainties in clinical research.

Authors:  Benjamin Djulbegovic
Journal:  J Med Philos       Date:  2007 Mar-Apr

9.  STREPTOMYCIN treatment of pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1948-10-30

10.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.

Authors:  Patricia M Kearney; Colin Baigent; Jon Godwin; Heather Halls; Jonathan R Emberson; Carlo Patrono
Journal:  BMJ       Date:  2006-06-03
View more
  11 in total

1.  Financial conflicts of interest in clinical research.

Authors:  Jelena Savović; Elie A Akl; Asbjørn Hróbjartsson
Journal:  Intensive Care Med       Date:  2018-08-20       Impact factor: 17.440

2.  Industry sponsorship and research outcome: systematic review with meta-analysis.

Authors:  Andreas Lundh; Joel Lexchin; Barbara Mintzes; Jeppe B Schroll; Lisa Bero
Journal:  Intensive Care Med       Date:  2018-08-21       Impact factor: 17.440

3.  Blood on our hands: seeing the evil in inappropriate comparators.

Authors:  Kamran Abbasi
Journal:  J R Soc Med       Date:  2013-01       Impact factor: 5.344

4.  Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement.

Authors:  Frank T Leone; Kai-Håkon Carlsen; David Chooljian; Laura E Crotty Alexander; Frank C Detterbeck; Michelle N Eakin; Sarah Evers-Casey; Harold J Farber; Patricia Folan; Hasmeena Kathuria; Karen Latzka; Shane McDermott; Sharon McGrath-Morrow; Farzad Moazed; Alfred Munzer; Enid Neptune; Smita Pakhale; David P L Sachs; Jonathan Samet; Beth Sufian; Dona Upson
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

Review 5.  A Whole Food Plant-Based Diet Is Effective for Weight Loss: The Evidence.

Authors:  Michael Greger
Journal:  Am J Lifestyle Med       Date:  2020-04-03

6.  Increasing value and reducing waste in research design, conduct, and analysis.

Authors:  John P A Ioannidis; Sander Greenland; Mark A Hlatky; Muin J Khoury; Malcolm R Macleod; David Moher; Kenneth F Schulz; Robert Tibshirani
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

7.  When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guilt.

Authors:  Benjamin Djulbegovic; Iztok Hozo
Journal:  BMC Med Res Methodol       Date:  2012-06-22       Impact factor: 4.615

Review 8.  Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.

Authors:  Adriani Nikolakopoulou; Dimitris Mavridis; Toshi A Furukawa; Andrea Cipriani; Andrea C Tricco; Sharon E Straus; George C M Siontis; Matthias Egger; Georgia Salanti
Journal:  BMJ       Date:  2018-02-28

9.  TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases.

Authors:  Lieven Annemans; Amr Makady
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

10.  New treatments compared to established treatments in randomized trials.

Authors:  Benjamin Djulbegovic; Ambuj Kumar; Paul P Glasziou; Rafael Perera; Tea Reljic; Louise Dent; James Raftery; Marit Johansen; Gian Luca Di Tanna; Branko Miladinovic; Heloisa P Soares; Gunn E Vist; Iain Chalmers
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.